Daniel Abdun-nabi - Net Worth and Insider Trading
Daniel Abdun-nabi Net Worth
The estimated net worth of Daniel Abdun-nabi is at least $2 Million dollars as of 2024-11-13. Daniel Abdun-nabi is the CEO of Emergent BioSolutions Inc and owns about 144,553 shares of Emergent BioSolutions Inc (EBS) stock worth over $2 Million. Daniel Abdun-nabi is also the Director of Aptevo Therapeutics Inc and owns about 178 shares of Aptevo Therapeutics Inc (APVO) stock worth over $49. Details can be seen in Daniel Abdun-nabi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Abdun-nabi has not made any transactions after 2019-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Abdun-nabi
Daniel Abdun-nabi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Abdun-nabi owns 3 companies in total, including Aptevo Therapeutics Inc (APVO) , Regenxbio Inc (RGNX) , and Emergent BioSolutions Inc (EBS) .
Click here to see the complete history of Daniel Abdun-nabi’s form 4 insider trades.
Insider Ownership Summary of Daniel Abdun-nabi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APVO | Aptevo Therapeutics Inc | 2019-06-25 | director |
| RGNX | Regenxbio Inc | 2016-08-05 | director |
| EBS | Emergent BioSolutions Inc | 2019-03-04 | director & President & COO |
Daniel Abdun-nabi Latest Holdings Summary
Daniel Abdun-nabi currently owns a total of 2 stocks. Among these stocks, Daniel Abdun-nabi owns 144,553 shares of Emergent BioSolutions Inc (EBS) as of March 4, 2019, with a value of $2 Million and a weighting of 100%. Daniel Abdun-nabi also owns 178 shares of Aptevo Therapeutics Inc (APVO) as of June 25, 2019, with a value of $49 and a weighting of 0%.
Latest Holdings of Daniel Abdun-nabi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2019-03-04 | 144,553 | 10.89 | 1,574,182 |
| APVO | Aptevo Therapeutics Inc | 2019-06-25 | 178 | 0.27 | 49 |
Holding Weightings of Daniel Abdun-nabi
Daniel Abdun-nabi Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Abdun-nabi has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 14,565 shares on March 4, 2019, which brought Daniel Abdun-nabi around $846,372.
According to the SEC Form 4 filings, Daniel Abdun-nabi has made a total of 0 transactions in Aptevo Therapeutics Inc (APVO) over the past 5 years. The most-recent trade in Aptevo Therapeutics Inc is the acquisition of 27 shares on June 25, 2019, which cost Daniel Abdun-nabi around $15,000.
Insider Trading History of Daniel Abdun-nabi
- 1
Daniel Abdun-nabi Trading Performance
GuruFocus tracks the stock performance after each of Daniel Abdun-nabi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Abdun-nabi is 1.96%. GuruFocus also compares Daniel Abdun-nabi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Abdun-nabi within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Abdun-nabi's insider trading performs compared to the benchmark.
Performance of Daniel Abdun-nabi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.1 | | | | | |
| Relative Return to S&P 500(%) | 1.78 | | | | | |
Daniel Abdun-nabi Ownership Network
Ownership Network List of Daniel Abdun-nabi
Ownership Network Relation of Daniel Abdun-nabi
Daniel Abdun-nabi Owned Company Details
What does Aptevo Therapeutics Inc do?
Who are the key executives at Aptevo Therapeutics Inc?
Daniel Abdun-nabi is the director of Aptevo Therapeutics Inc. Other key executives at Aptevo Therapeutics Inc include SVP & CFO Daphne Taylor , 10 percent owner Kevin C Tang , and See Remarks Soyoung Kwon .
Aptevo Therapeutics Inc (APVO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptevo Therapeutics Inc (APVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptevo Therapeutics Inc (APVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptevo Therapeutics Inc (APVO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptevo Therapeutics Inc Insider Transactions
Daniel Abdun-nabi Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Abdun-nabi. You might contact Daniel Abdun-nabi via mailing address: 400 Professional Drive, Suite 400, Gaithersburg Md 20879.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
